glp-1 digestive blockage law office in louisiana lawmakers are considering a bill that would expand Medicaid access to drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Digger Earles Honored With Appointment

Description

Ensuring equitable access and strengthening health systems will be essential to prevent widening health disparities.AgendaCo-chairsDr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMAModeratorDr Gaya Manori Gamhewage, Director, Department of Communication, WHOWelcomingDr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMAPresentation:WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adultsDr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr

Based on promising findings from this initial consumer study, Pendulum is planning additional clinical trials to further our scientific understanding

Several new weight loss treatments are in development, including Amgen's MariTide

Women are getting pregnant while taking medications like Ozempic, Wegovy, Zepbound, Mounjaro, Saxenda, Trulicity, and Victoza.In many cases, the posts start the same way: "We'd been trying for years." "I thought I couldn't get pregnant." "I was waiting to start fertility treatment."Then comes the surprise positive pregnancy test